<DOC>
	<DOCNO>NCT00905645</DOCNO>
	<brief_summary>Safety effectiveness Silimed Gel-Filled Mammary Implant indicate primary augmentation , primary reconstruction , and/or revision female breast .</brief_summary>
	<brief_title>Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Subjects admit study follow eligibility true : Female Age limitation specific indication : Primary Augmentation : Must 18 year old Primary Reconstruction : No age limit Revision : If original surgery primary reconstruction , age limit . If original surgery primary augmentation , must 18 year old . Adequate tissue available cover implant ( ) Willingness follow study requirement ( informed consent form , followup visit ) Candidate primary augmentation , primary reconstruction , revision Exclusion Criteria Subjects eligible follow criterion exist : Advanced fibrocystic disease , consider premalignant without mastectomy Inadequate unsuitable tissue Active infection body time surgery Pregnant lactate Medical condition might result unduly high surgical risk and/or significant postoperative complication , judgment Investigator Use drug , include drug would interfere blood clotting , might result high risk and/or significant postoperative complication Demonstrated psychological characteristic unrealistic unreasonable give risk involve surgical procedure Determination physical examination subject connective tissue/autoimmune disorder Existing carcinoma breast without accompany mastectomy MRI scan prohibit implanted metal device , claustrophobia , condition .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Breast Augmentation</keyword>
	<keyword>Breast Reconstruction</keyword>
	<keyword>Breast Revision</keyword>
	<keyword>Silicone breast implant</keyword>
</DOC>